Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil

Adams, 2012, Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer, Clin. Cancer Res., 18, 6748, 10.1158/1078-0432.CCR-12-1149 Applequist, 2002, Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines, Int. Immunol., 14, 1065, 10.1093/intimm/dxf069 Banerjee, 2006, Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells, Proc. Natl. Acad. Sci. U. S. A., 103, 3274, 10.1073/pnas.0511113103 Basith, 2012, Roles of toll-like receptors in cancer: a double-edged sword for defense and offense, Arch. Pharm. Res., 35, 1297, 10.1007/s12272-012-0802-7 Bauer, 2001, Bacterial CpG-DNA triggers activation and maturation of human CD11c−, CD123+ dendritic cells, J. Immunol., 166, 5000, 10.4049/jimmunol.166.8.5000 Blander, 2004, Regulation of phagosome maturation by signals from toll-like receptors, Science, 304, 1014, 10.1126/science.1096158 Brown, 2011, Natural killer cell mediated cytotoxic responses in the Tasmanian devil, PLoS One, 6, e24475, 10.1371/journal.pone.0024475 Brozek, 1992, Proliferative responses of lymphocytes to mitogens in the gray, short-tailed opossum, Monodelphis domestica, Vet. Immunol. Immunopathol., 31, 11, 10.1016/0165-2427(92)90083-3 Casares, 2005, Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death, J. Exp. Med., 202, 1691, 10.1084/jem.20050915 Cowled, 2011, Molecular characterisation of Toll-like receptors in the black flying fox Pteropus alecto, Dev. Comp. Immunol., 35, 7, 10.1016/j.dci.2010.07.006 Cui, 2015, Diversity in the Toll-like receptor genes of the Tasmanian devil (Sarcophilus harrisii), Immunogenetics, 67, 195, 10.1007/s00251-014-0823-0 Cui, 2015, SNP marker discovery in koala TLR genes, PLoS One, 10, e0121068, 10.1371/journal.pone.0121068 Deakin, 2012, Genomic restructuring in the Tasmanian devil facial tumour: chromosome painting and gene mapping provide clues to evolution of a transmissible tumour, PLoS Genet., 8, e1002483, 10.1371/journal.pgen.1002483 Flies, 2014, Characterization of Toll-like receptors 1-10 in spotted hyenas, Vet. Res. Commun., 38, 165, 10.1007/s11259-014-9592-3 Galluzzi, 2012, Trial Watch: experimental Toll-like receptor agonists for cancer therapy, Oncoimmunology, 1, 699, 10.4161/onci.20696 Hamede, 2008, Seasonal, demographic and density-related patterns of contact between Tasmanian devils (Sarcophilus harrisii): Implications for transmission of devil facial tumour disease, Austral Ecol., 33, 614, 10.1111/j.1442-9993.2007.01827.x Hawkins, 2006, Emerging disease and population decline of an island endemic, the Tasmanian devil (Sarcophilus harrisii), Biol. Conserv., 131, 307, 10.1016/j.biocon.2006.04.010 He, 2007, TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance, Mol. Immunol., 44, 2850, 10.1016/j.molimm.2007.01.022 Hemmi, 2002, Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway, Nat. Immunol., 3, 196, 10.1038/ni758 Hemmi, 2004, The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection, J. Exp. Med., 199, 1641, 10.1084/jem.20040520 Hornung, 2002, Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG Oligodeoxynucleotides, J. Immunol., 168, 4531, 10.4049/jimmunol.168.9.4531 Howson, 2014, Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors, Anat. Rec. (Hoboken), 297, 925, 10.1002/ar.22904 Inoue, 2014, Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments, Cell Death Differ., 21, 39, 10.1038/cdd.2013.84 Kaiser, 2013, Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL, J. Biol. Chem., 288, 31268, 10.1074/jbc.M113.462341 Kassianos, 2010, Isolation of human blood DC subtypes, Methods Mol. Biol., 595, 45, 10.1007/978-1-60761-421-0_3 Kreiss, 2015, Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations, Vaccine, 10.1016/j.vaccine.2015.01.039 Kreiss, 2011, Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity, PLoS One, 6, e22402, 10.1371/journal.pone.0022402 Kreiss, 2008, Assessment of cellular immune responses of healthy and diseased Tasmanian devils (Sarcophilus harrisii), Dev. Comp. Immunol., 32, 544, 10.1016/j.dci.2007.09.002 Kreiss, 2009, A histological and immunohistochemical analysis of lymphoid tissues of the Tasmanian devil, Anat. Rec. (Hoboken), 292, 611, 10.1002/ar.20896 Kreiss, 2009, The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against horse red blood cells, Vet. Immunol. Immunopathol., 130, 135, 10.1016/j.vetimm.2009.02.003 Krug, 2001, Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12, Eur. J. Immunol., 31, 3026, 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H Krutzik, 2005, TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells, Nat. Med., 11, 653, 10.1038/nm1246 Lehner, 2007, Efficient chemokine-dependent migration and primary and secondary IL-12 secretion by human dendritic cells stimulated through Toll-like receptors, J. Immunother., 30, 312, 10.1097/01.cji.0000211345.11707.46 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 Loh, 2006, The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii), Vet. Pathol., 43, 896, 10.1354/vp.43-6-896 Luo, 2012, Activation of Toll-like receptor 3 induces apoptosis of oral squamous carcinoma cells in vitro and in vivo, Int. J. Biochem. Cell Biol., 44, 1266, 10.1016/j.biocel.2012.04.025 McCallum, 2009, Transmission dynamics of Tasmanian devil facial tumor disease may lead to disease-induced extinction, Ecology, 90, 3379, 10.1890/08-1763.1 Medzhitov, 1997, A human homologue of the Drosophila Toll protein signals activation of adaptive immunity, Nature, 388, 394, 10.1038/41131 Medzhitov, 1998, MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways, Mol. Cell, 2, 253, 10.1016/S1097-2765(00)80136-7 Miconnet, 2002, CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide, J. Immunol., 168, 1212, 10.4049/jimmunol.168.3.1212 Murchison, 2012, Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer, Cell, 148, 780, 10.1016/j.cell.2011.11.065 Murchison, 2010, The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer, Science, 327, 84, 10.1126/science.1180616 Napolitani, 2005, Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells, Nat. Immunol., 6, 769, 10.1038/ni1223 Ninomiya-Tsuji, 1999, The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway, Nature, 398, 252, 10.1038/18465 Obeid, 2007, Calreticulin exposure dictates the immunogenicity of cancer cell death, Nat. Med., 13, 54, 10.1038/nm1523 Paone, 2008, Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism, Carcinogenesis, 29, 1334, 10.1093/carcin/bgn149 Pearse, 2006, Allograft theory: transmission of devil facial-tumour disease, Nature, 439, 549, 10.1038/439549a Pinfold, 2014, Mouse model of devil facial tumour disease establishes that an effective immune response can be generated against the Cancer cells, Front. Immunol., 5, 251, 10.3389/fimmu.2014.00251 Qian, 2001, IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFkappa B, J. Biol. Chem., 276, 41661, 10.1074/jbc.M102262200 Riccardi, 2006, Analysis of apoptosis by propidium iodide staining and flow cytometry, Nat. Protoc., 1, 1458, 10.1038/nprot.2006.238 Roach, 2005, The evolution of vertebrate Toll-like receptors, Proc. Natl. Acad. Sci. U. S. A., 102, 9577, 10.1073/pnas.0502272102 Schnare, 2001, Toll-like receptors control activation of adaptive immune responses, Nat. Immunol., 2, 947, 10.1038/ni712 Schon, 2003, Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod, J. Natl. Cancer Inst., 95, 1138, 10.1093/jnci/djg016 Schon, 2004, Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod, J. Invest Dermatol, 122, 1266, 10.1111/j.0022-202X.2004.22528.x Schwarz, 2003, Role of Toll-like receptors in costimulating cytotoxic T cell responses, Eur. J. Immunol., 33, 1465, 10.1002/eji.200323919 Siddle, 2013, Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer, Proc. Natl. Acad. Sci. U. S. A., 110, 5103, 10.1073/pnas.1219920110 Sohn, 2014, Imiquimod induces apoptosis of squamous cell carcinoma (SCC) cells via regulation of A20, PLoS One, 9, e95337, 10.1371/journal.pone.0095337 Song, 2011, Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5, Int. J. Mol. Med., 28, 115 Tirumurugaan, 2010, Differential expression of toll-like receptor mRNA in selected tissues of goat (Capra hircus), Vet. Immunol. Immunopathol., 133, 296, 10.1016/j.vetimm.2009.08.015 Vacchelli, 2013, Trial Watch: toll-like receptor agonists for cancer therapy, Oncoimmunology, 2, e25238, 10.4161/onci.25238 Vahanan, 2008, Expression profile of toll like receptors in a range of water buffalo tissues (Bubalus bubalis), Vet. Immunol. Immunopathol., 126, 149, 10.1016/j.vetimm.2008.05.027 Vollmer, 2004, Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities, Eur. J. Immunol., 34, 251, 10.1002/eji.200324032 Warger, 2006, Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo, Blood, 108, 544, 10.1182/blood-2005-10-4015 Wilkinson, 1992, Isolation of koala lymphoid cells and their in vitro responses to mitogens, Vet. Immunol. Immunopathol., 31, 21, 10.1016/0165-2427(92)90084-4 Woods, 2007, The immune response of the Tasmanian Devil (Sarcophilus harrisii) and devil facial tumour disease, Ecohealth, 4, 338, 10.1007/s10393-007-0117-1 Xie, 2009, Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells, Biochem. Biophys. Res. Commun., 379, 1027, 10.1016/j.bbrc.2009.01.009 Yamamoto, 2003, Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway, Science, 301, 640, 10.1126/science.1087262 Yamaoka, 1998, Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation, Cell, 93, 1231, 10.1016/S0092-8674(00)81466-X Zhu, 2008, Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines, Proc. Natl. Acad. Sci. U. S. A., 105, 16260, 10.1073/pnas.0805325105